Genenta Science S.p.A.
NASDAQ:GNTA
4.34 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 4.582 | 6.188 | 3.691 | 12.213 | 29.795 | 34.671 | 37.24 | 10.554 | 15.465 |
| Short Term Investments
| 8.078 | 10.718 | 15.084 | 9.999 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 12.66 | 16.906 | 18.776 | 22.212 | 29.795 | 34.671 | 37.24 | 10.554 | 15.465 |
| Net Receivables
| 1.448 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0.368 | 0.145 | 0.684 | 0.076 | 0.076 | 0.028 |
| Other Current Assets
| 0.365 | 1.698 | 2.515 | 2.304 | 1.927 | 2.737 | 1.519 | 1.55 | 1.069 |
| Total Current Assets
| 14.473 | 18.569 | 21.256 | 24.516 | 31.721 | 37.408 | 38.759 | 12.104 | 16.534 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 0.043 | 0.084 | 0.057 | 0.103 | 0.112 | 0.066 | 0.023 | 0.021 | 0.019 |
| Goodwill
| 0 | 0 | -0.035 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0.088 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0.053 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 1.891 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | -1.891 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.308 | 0.364 | 0.981 | 2.107 | 1.605 | 0.803 | 1.245 | 1.167 | 0.949 |
| Total Non-Current Assets
| 0.351 | 0.448 | 1.091 | 2.21 | 1.716 | 0.869 | 1.268 | 1.187 | 0.968 |
| Total Assets
| 14.824 | 19.017 | 22.347 | 26.726 | 33.438 | 38.278 | 40.027 | 13.291 | 17.502 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 0.318 | 0.406 | 0.295 | 0.479 | 1.194 | 0.526 | 0.19 | 0.359 | 0.555 |
| Short Term Debt
| 0 | 0.013 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 1.782 | 1.577 | 1.441 | 1.292 | 0.989 | 0.675 | 0.945 | 1.309 | 1.778 |
| Total Current Liabilities
| 2.099 | 1.996 | 1.736 | 1.772 | 2.184 | 1.201 | 1.135 | 1.668 | 2.333 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 0 | 0.008 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.229 | 0.196 | 0.179 | 0.15 | 0.116 | 0.088 | 0.031 | 0.022 | 0.017 |
| Total Non-Current Liabilities
| 0.229 | 0.204 | 0.179 | 0.15 | 0.116 | 0.088 | 0.031 | 0.022 | 0.017 |
| Total Liabilities
| 2.328 | 2.2 | 1.915 | 1.922 | 2.3 | 1.289 | 1.166 | 1.69 | 2.351 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 68.462 | 67.848 | 67.344 | 67.019 | 66.604 | 66.121 | 65.881 | 37.139 | 0.037 |
| Retained Earnings
| -56.056 | -51.182 | -47.143 | -42.215 | -35.466 | -29.132 | -27.02 | -25.538 | -21.49 |
| Accumulated Other Comprehensive Income/Loss
| 0.089 | 0.151 | 0.231 | 0 | 0 | 0 | 0 | -0 | -0 |
| Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36.605 |
| Total Shareholders Equity
| 12.496 | 16.817 | 20.432 | 24.804 | 31.138 | 36.989 | 38.861 | 11.601 | 15.151 |
| Total Equity
| 12.496 | 16.817 | 20.432 | 24.804 | 31.138 | 36.989 | 38.861 | 11.601 | 15.151 |
| Total Liabilities & Shareholders Equity
| 14.824 | 19.017 | 22.347 | 26.726 | 33.438 | 38.278 | 40.027 | 13.291 | 17.502 |